{"id":9222,"date":"2026-05-25T20:55:00","date_gmt":"2026-05-25T20:55:00","guid":{"rendered":"https:\/\/cdafound.org\/?p=9222"},"modified":"2026-06-03T21:05:41","modified_gmt":"2026-06-03T21:05:41","slug":"from-targets-to-real-world-impact-a-review-of-models-of-care-for-chronic-hbv-and-hcv-in-europe","status":"publish","type":"post","link":"https:\/\/cdafound.org\/es\/from-targets-to-real-world-impact-a-review-of-models-of-care-for-chronic-hbv-and-hcv-in-europe\/","title":{"rendered":"De los objetivos al impacto en el mundo real: una revisi\u00f3n de los modelos de atenci\u00f3n para la hepatitis B cr\u00f3nica y la hepatitis C en Europa."},"content":{"rendered":"<p>El virus de la hepatitis B (VHB) y el virus de la hepatitis C (VHC) siguen representando una amenaza para la salud p\u00fablica en la regi\u00f3n europea de la OMS, donde se estima que 29 millones de personas viven con infecci\u00f3n cr\u00f3nica y las muertes relacionadas con la hepatitis viral superan actualmente las causadas por el VIH\/SIDA y la tuberculosis juntas. Si bien las herramientas de prevenci\u00f3n eficaces y los tratamientos antivirales reducen el riesgo de complicaciones, la mortalidad general no ha disminuido. Este documento de la serie revisa los modelos de atenci\u00f3n (MdA) implementados entre 2015 y 2025, bas\u00e1ndose en la literatura cient\u00edfica y los documentos de pol\u00edtica para evaluar el progreso regional. Las pruebas y tratamientos simplificados, la vacunaci\u00f3n infantil y dirigida a adultos contra el VHB, los programas de reducci\u00f3n de da\u00f1os y las intervenciones en las c\u00e1rceles han impulsado los esfuerzos de eliminaci\u00f3n. Los enfoques pragm\u00e1ticos, que incluyen pruebas en el punto de atenci\u00f3n, servicios descentralizados y modelos integrados adaptados a poblaciones clave, demuestran claros beneficios. Sin embargo, persisten importantes desaf\u00edos: grandes poblaciones sin diagnosticar, disparidades regionales, conocimientos insuficientes del personal sanitario e inequidades que afectan a los grupos de riesgo. Para lograr la eliminaci\u00f3n de la enfermedad en 2030 se requerir\u00e1 una detecci\u00f3n de casos m\u00e1s r\u00e1pida, un mayor acceso a tratamientos simplificados, estrategias de vacunaci\u00f3n y de prevenci\u00f3n m\u00e1s eficaces adaptadas al riesgo, mejores sistemas de datos y un compromiso renovado.<\/p>\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-outline is-style-outline--1\"><a class=\"wp-block-button__link has-text-color wp-element-button\" href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2026\/06\/Picchio-2026-CLD-Europe.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Lea el informe completo<\/a><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Hepatitis B virus (HBV) and hepatitis C virus (HCV) remain public health threats in the WHO European region, where an estimated 29 million people live with chronic infection and viral hepatitis-related deaths now surpass those from HIV\/AIDS and tuberculosis combined. Although effective prevention tools and antiviral treatments reduce the risk of complications, overall mortality has [&hellip;]<\/p>\n","protected":false},"author":939,"featured_media":3227,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[9],"tags":[31,21,2762,2765,2766,2763,2764,2767],"publication-author":[2752,226,2758,2706,80,2756,2757,296,2737,2761,2755,2753,2760,245,2754,2759],"class_list":["post-9222","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publication","tag-elimination","tag-hbv","tag-infectious-disease-control","tag-linkage-to-care","tag-models-of-care","tag-monitoring","tag-prevention","tag-testing","publication-author-aina-nicolas","publication-author-alessio-aghemo","publication-author-axelle-vanderlinden","publication-author-camila-a-picchio","publication-author-devin-razavi-shearer","publication-author-elisa-martro","publication-author-erika-duffell","publication-author-joaquin-cabezas","publication-author-peter-vickerman","publication-author-philippa-c-matthews","publication-author-rachel-halford","publication-author-sabela-lens","publication-author-sandra-dudareva","publication-author-thomas-vanwolleghem","publication-author-upkar-s-gill","publication-author-xavier-forns"],"acf":[],"_links":{"self":[{"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/posts\/9222","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/users\/939"}],"replies":[{"embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/comments?post=9222"}],"version-history":[{"count":1,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/posts\/9222\/revisions"}],"predecessor-version":[{"id":9224,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/posts\/9222\/revisions\/9224"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/media\/3227"}],"wp:attachment":[{"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/media?parent=9222"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/categories?post=9222"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/tags?post=9222"},{"taxonomy":"publication-author","embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/publication-author?post=9222"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}